Category Archives: Transhuman News

Beata Kowalewska,1 Barbara Jankowiak,1 Mateusz Cybulski,1 Elbieta Krajewska-Kuak,1 Dzmitry Fiodaravich Khvorik2

1Department of Integrated Medical Care, Medical University of Bialystok, Bialystok, Poland; 2Department of Dermatovenerology, Medical University in Grodno, Grodno, Belarus

Correspondence: Beata KowalewskaDepartment of Integrated Medical Care, Medical University of Bialystok, 7A Curie-Skodowskiej Str., Bialystok, 15-096, PolandTel +48 85 748 55 28Email beata.kowalewska@umb.edu.pl

Introduction: Psoriasis is a chronic inflammatory disease of the skin having a profound effect on the quality of life and contributing to the sense of stigmatization in the affected patients. The aim of this study was to analyze the effect of psoriasis severity on the quality of life and sense of stigmatization in psoriatics and to investigate relationships between these measures and sociodemographic variables.Patients and Methods: The study included 111 patients with psoriasis. The inclusion criteria of the study were the diagnosis of psoriasis and written informed consent to participate. The study was based on a short survey prepared by the authors and four validated scales: Dermatology Life Quality Index (DLQI), 6-item Stigmatization Scale, 33-item Feelings of Stigmatization Questionnaire, and Psoriasis Area and Severity Index (PASI).Results: Mean PASI score for the study group was 14 pts. Most respondents presented with low DLQI scores, with the mean value of 10.8 pts suggesting that the disease-related ailments were not extremely burdensome for the majority of the patients. Mean stigmatization scores for the 6- and 33-item scale were 7 8 and 81 82 pts, respectively.Conclusion: The severity of psoriasis was the strongest determinant of the quality of life measured with the DLQI. Also, the levels of stigmatization determined with the 6- and 33-item scale correlated significantly with PASI scores.

Keywords: psoriasis, quality of life, stigmatization, psoriasis severity, psychodermatology, DLQI, PASI

This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License.By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

See the original post here:
Effect of Disease Severity on the Quality of Life and Sense of Stigmat | CCID - Dove Medical Press

Almost one-third of people with moderate to severe psoriasis suffer from mental health issues like anxiety and depression. Almirall wants to change that througha new collaboration with Happify Health.

The Barcelona-based pharma will launch a digital wellness program called Claro with Happify, which develops digital therapeutics for people with chronic disease, leaning on its team of scientists, physicians and gaming experts to help people manage mental health.

RELATED: Almirall 'Shared Skin' dermatology disease awareness campaign gets employees involved

The new Almirall program will feature a user experience the company called "meaningful, dynamic and fun," and it willbe delivered through the pharma companys patient support program in the U.K., Spain, Italy and France.

Almirall chose Happify because of its demonstrated positive impact on the mental health of patients with chronic conditions, including psoriasis, in published research, Francesca Domenech Wuttke, Almiralls chief digital officer, said.

The medical dermatology-focused pharma nabbed a recent approval in France for Ilumetri, an anti-IL-23p19 to treat psoriasis, with a launch expected soon. Almirall has a development and sales license for Ilumetri with Sun Pharmaceutical in Europe with launches already underway in Germany, the U.K., Switzerland, Austria, Denmark, Italy, Belgium, the Netherlands and Spain.

RELATED: Allergan preludes major selloffs with $650M Almirall dermatology sale

Almirall sharpened its focus in dermatology in 2018 when it acquired Allergans medical dermatology portfolio. The $650 million deal included brands Aczone, Tazorac, Azelex, Cordran Tape and Seysara.

Digital therapeutics, meanwhile, have been hit or miss in the pharma space, with some pioneers in the field already having moved on. Novartis ended itsPear Therapeutics partnership in 2019 after helping bring to marketthefirst FDA-approved digital therapeuticsreSET and reSET-O for substance use disorder and opioid use disorderand the first directlydetailedby a drugmaker. At the time, Novartis' Sandoz said Pear was now able to support its own commercial operations.

Otsuka and Proteus' mental health "digital pill" partnership also dissolved last year. Otsuka now owns thedigital therapeutics, including theAbilify MyCite smart pill technology, after a bankruptcy court winin August.

More digital therapeutics fromOrexo launchedlastfall, too: Vorvidafor problematic drinking and Deprexis for depression. Orexoalso markets drug products including Subsolv for opioid use disorder.

The rest is here:
Almirall enlists Happify to boost psoriasis patients' mental health with digital therapeutics - FiercePharma

When you have psoriasis, the right workout clothes keep your skin happy so you can better enjoy exercising.

Image Credit: LumiNola/E+/GettyImages

If you have psoriasis, you may put a lot of thought into the clothes you wear. Maybe you strategically choose pieces that cover up affected areas of your skin or ones that make you feel your best. But perhaps the most important reason is the fact that what you wear can keep your skin happy or lead to a flare-up.

Psoriasis a skin disease marked by red, itchy patches of skin covered with silvery scales tends to come and go in cycles, going from remission to flaring again if something sets it off, according to the Mayo Clinic. Certain types of clothing can sometimes be the trigger.

The general recommendation is to avoid tight-fitting clothes, because they may irritate the skin, says Lisa Anthony, MD, a board-certified dermatologist at Westmed Medical Group. That might sound like a problem, because that eliminates most popular styles of workout clothing but don't let that keep you away from exercise.

"Regular exercise is not only a great way to de-stress and build confidence, but it will improve heart health," Dr. Anthony says, adding that people with psoriasis are at increased risk of cardiovascular health problems.

You'll just need to be strategic about how you dress for your workouts. Here's a guide to choosing the best workout clothes when you have psoriasis, including general tips on what to look for and a few specific pieces that fit within those guidelines.

No matter what you decide to exercise in, be sure to wash your workout clothes in detergents that are gentle on the skin. Laundry detergents that are fragrance-free and dye-free are recommended to reduce the risk of irritation, Dr. Anthony says.

The Best Workout Tops When You Have Psoriasis

When shopping for workout tops, you'll want to avoid tight, form-fitting styles if you can, because they can rub against the skin and lead to irritation, Dr. Anthony says. "Looser-fitting clothing will reduce friction and trauma to the skin," she says.

1. JoyLab Womens Tie-Back Active Tank Top

Image Credit: LIVESTRONG.com Creative

This loose-fitting tank from Target's activewear line features an open back, which amps up the breathability and minimizes contact between the fabric and your skin. We also love it for its affordable price and punchy style.

2. Outdoor Voices Ready Set Shortsleeve

Image Credit: LIVESTRONG.com Creative

This Austin-based brand offers a full line of gear designed to get you moving. To start, go for this versatile tee. Its boxy fit and slightly cropped length keep the air flowing. Plus, it's made out of OV's Sweatee fabric, a performance cotton with sweat-wicking properties.

3. Zella Splits Ribbed Tank

Image Credit: LIVESTRONG.com Creative

Because a loose fit is the way to go, this racerback tank from Zella is another good addition to your workout wardrobe.

Pro tip: Choose the white color instead of black Dr. Anthony says wearing light colors will minimize the appearance of flakes.

The Best Sports Bras When You Have Psoriasis

It's hard to get away from a tight fit when shopping for sports bras. So focus on fabric instead. Some materials, such as synthetic fabrics and wool, can cause skin irritation and thereby a psoriasis breakout, Dr. Anthony says.

"To minimize skin irritation, choose cotton fabric that is more breathable or a performance fabric that reduces irritation from sweat and moisture," she says.

1. Splits59 Bianca Techflex Bra

Image Credit: LIVESTRONG.com Creative

Andrea Fornarola, CPT, ACE, an AFAA-certified fitness instructor and founder/CEO of Elements Fitness Studio, loves this line for her sensitive skin.

"The comfortable sports bras are supportive but don't have the uncomfortable, heavy elastic bands," she says.

This bra also features flatlock seams that minimize chafing a definite plus for psoriasis skin.

2. Athleta Ultimate Printed Bra

Image Credit: LIVESTRONG.com Creative

Look for the SuperSonic fabric from this Gap-owned brand it's designed specifically to wick sweat away from the skin and dry quickly to keep your skin fresh.

You've got a few options if you're sticking to light colors, including orchid pink, white and oasis blue. Plus, you're bound to find a size that fits your body this sports bra is available in size XXS to 3X.

Image Credit: LIVESTRONG.com Creative

The Elevation Bra from this California-based brand offers a supportive fit that'll keep up with even your most intense workouts. It's also made with a moisture-wicking material and scores style points for its high neck and strappy back.

4. lululemon Like a Cloud Bra Light Support

Image Credit: LIVESTRONG.com Creative

If the day is calling for a lower-impact workout like yoga, consider this light-support sports bra from lululemon. This bra features four skinny straps, which is an on-trend design choice and also a good choice for those with psoriasis because it leaves lots of space for skin to breathe.

The Best Workout Bottoms When You Have Psoriasis

You'll want to follow all the same advice when shopping for workout bottoms: breathable fabrics and loose fits will minimize the risk of flare-ups.

1. lululemon Hotty Hot Short High-Rise Long

Image Credit: LIVESTRONG.com Creative

These four-inch shorts (also available in a shorter style) feature the Canadian retailer's lightweight Swift fabric, which combines stretchiness, sweat-wicking properties and mesh side panels for extra ventilation.

2. Athleta Salutation Stash Pocket II 7/8 Tight

Image Credit: LIVESTRONG.com Creative

Fornarola turns to Athleta for the brand's "really comfortable high-waisted leggings that stay in place and breath as your body heats up and cools down."

This style features the brand's super-soft Powervita fabric and side pockets beneath the hips for storage.

3. Nike Dri-FIT Attack Shorts

Image Credit: LIVESTRONG.com Creative

The lightweight, sweat-wicking material on these Nike workout shorts gives you room to move and your skin room to breathe.

Buy it: Nike.com; Price: $25

4. GapFit Runaround Joggers

Image Credit: LIVESTRONG.com Creative

The looser fit and breathable quick-dry fabric make these GapFit joggers a must-have for low-intensity workouts (and for lounging post-workout, too). Choose from a range of light colors, including white, tan khaki, pink English rose and vintage palm.

Buy it: Gap.com; Price: $47-$70

See the original post:
The Best Workout Clothes When You Have Psoriasis - LIVESTRONG.COM

Psoriasis and eczema are both common skin conditions. Eczema affects about 31.6 million people in the United States, while as many as 7.5 million suffer from psoriasis. Both cause red, itchy skin, and they can sometimes look so much alike that some doctors, especially general practitioners, may have trouble distinguishing between them though they look quite different to dermatologists.

Both psoriasis and eczema are autoimmune diseases the former being the most prevalent autoimmune disease in the United States. Psoriasis causes the life cycle of skin cells to accelerate. The dead cells build up on the skin instead of being sloughed off. The disease is believed to be caused by overactive T cells and other white blood cells, which both attack healthy skin cells and trigger increased skin cell production.

Eczema is triggered primarily by exposure to bacteria, allergens, or various other irritants, and may be more prevalent in those who have a genetic variation that affects the skins ability to protect itself. The main risk factor for eczema is a family or personal history of asthma, hay fever, allergies, or eczema itself.

Eczema is an umbrella term, describing various related conditions that cause inflamed, itchy skin, according to the National Eczema Association. They recognize six types. The most common kind, and the one that most of us think of as eczema, is correctly called atopic dermatitis. It usually appears in the crooks of the elbows or knees, though it may also affect the back of the neck and the face. The main risk factor for atopic dermatitis is a family or personal history of asthma, hay fever, allergies, or the condition itself.

There are likewise several kinds of psoriasis, seven in all, the most common being plaque psoriasis. This condition causes raised, dry, scaly red lesions, typically on elbows and knees, though the lesions can appear anywhere on the body, including the face and the inside of the mouth.

There is no cure for either atopic dermatitis or psoriasis, and both are chronic conditions, often coming and going. Preventative measures may stave off flare-ups of either one, however. Doctors recommend that those affected try to identify and avoid factors that may set off bouts of the disease. Such factors include stress and obesity. Smoking increases the risk of psoriasis and can make it worse. Infants and children affected with eczema may experience flare-ups from eating potentially allergenic foods.

Both conditions react negatively to cold, dry weather, and both may be partially soothed by keeping the skin well lubricated and by using only gentle soaps. The American Academy of Dermatology also recommends bathing in a well-diluted solution of household bleach to prevent flare-ups of atopic dermatitis.

Continued here:
Whats the Difference Between Eczema and Psoriasis? - 24/7 Wall St.

Global Tumor Necrosis Factor Inhibitor Drugs Market: Overview

Tumor necrosis factor or TNF refers to a multifunctional protein cytokine that is produced by immune cells. This protein cytokine causes inflammation in body and has an important role to play in many of the cellular functions such as death, survival, differentiation, and cell proliferation. Tumor necrosis factor inhibitors subdue innate response of the body toward tumor necrosis factor. Tumor necrosis factor inhibitors are drugs that assist in stopping inflammation in the body. These drugs are utilized in the treatment of various diseases, such as Crohn's disease, ulcerative colitis, ankylosing spondylitis, plaque psoriasis, psoriatic arthritis, juvenile arthritis, and rheumatoid arthritis. They are also otherwise known as anti-TNF drugs, biologic therapies, and TNF blockers. Food and Drug Administration of the US has approved many TNF inhibitors for use.

Request Brochure of Report - https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=77950

Product, application, sales channel, and region are the four important parameters based on which the classification of the global tumor necrosis factor inhibitor drugs market has been done. Such dissection of the market comes with the purpose to offer stakeholders with a detailed and clear analysis of the global tumor necrosis factor inhibitor drugs market.

Request for Analysis of COVID-19 Impact on Tumor Necrosis Factor Inhibitor Drugs Market - https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=77950

Global Tumor Necrosis Factor Inhibitor Drugs Market: Notable Developments

One of the recent market developments that offers a glimpse of the market dynamics at play in the global tumor necrosis factor inhibitor drugs market is mentioned below:

Pre Book Tumor Necrosis Factor Inhibitor Drugs Market Report at https://www.transparencymarketresearch.com/checkout.php?rep_id=77950&ltype=S

Some of the prominent organizations in the global tumor necrosis factor inhibitor drugs market include:

Read more information here:

https://www.transparencymarketresearch.com/tumor-necrosis-factor-inhibitor-drugs-market.html

Global Tumor Necrosis Factor Inhibitor Drugs Market: Key Trends

The global tumor necrosis factor inhibitor drugs market is characterized by the presence of the following restraints, drivers, and opportunities.

Rise of Biosimilars to Pose Serious Internal Challenge to the Growth of the Market

The growth of the global tumor necrosis factor inhibitor drugs market is likely to be influenced by several factors. These growth factors for the market comprise increasing disposable income, augmented spending on healthcare, new product launches, growing geriatric population, increased prevalence of autoimmune disorders, and rise in the awareness level of people about these drugs. In addition, there has been a trend amongst consumers to opt for cost effective drugs with better safety and effectiveness is likely to drive the demand for tumor necrosis factor inhibitor drugs in the years to come.

The biologics prevalent in the global tumor necrosis factor inhibitor drugs market is faced with a direct internal threat from biosimilars. Loss of patent exclusivities across many regions of the world has worked in favor of the use of biosimilars. In addition to that, stiff competition from Interleukin (IL) inhibitors is likely to pose serious challenge to the growth of the global tumor necrosis factor inhibitor drugs market over the period of assessment.

About Us

Transparency Market Research is a next-generation market intelligence provider, offering fact-based solutions to business leaders, consultants, and strategy professionals.

Our reports are single-point solutions for businesses to grow, evolve, and mature. Our real-time data collection methods along with ability to track more than one million high growth niche products are aligned with your aims. The detailed and proprietary statistical models used by our analysts offer insights for making right decision in the shortest span of time. For organizations that require specific but comprehensive information we offer customized solutions through ad hoc reports. These requests are delivered with the perfect combination of right sense of fact-oriented problem solving methodologies and leveraging existing data repositories.

TMR believes that unison of solutions for clients-specific problems with right methodology of research is the key to help enterprises reach right decision.

Contact

Mr. Rohit BhiseyTransparency Market Research

State Tower,

90 State Street,

Suite 700,

Albany NY - 12207

United States

USA - Canada Toll Free: 866-552-3453

Email: sales@transparencymarketresearch.com

Website: https://www.transparencymarketresearch.com/

Visit link:
Tumor Necrosis Factor Inhibitor Drugs Market: Rise of Biosimilars to Pose Serious Internal Challenge to the Growth of the Market - BioSpace

Cannabidiol, a non-psychoactive compound derived from cannabis, has shown increasing influence in dermatologic research, but this compound currently lacks robust and long-term data to support its use in specific skin disorders. In spite of the lack of these data, several studies have reported the potential therapeutic effects of CBD in certain skin conditions, according to findings in a review article published in Clinical, Cosmetic and Investigational Dermatology.

Cutaneous biology, according to the authors of this review, is modulated by what is known as the human endocannabinoid system (ECS), and receptors from this system are found in the skin. The ECS is involved in maintaining barrier function and skin homeostasis, but system dysregulation may impair skin barrier function and ultimately lead to different skin disorders, such as atopic dermatitis, acne, and even hyperpigmentation and hypopigmentation.

The use of CBD in in vitro studies has been shown to induce HMOX1 expression as well as expression in other NRF2-regulated genes. Researchers theorize that CBD may be beneficial for skin disorders associated with free radical formation and inflammation, due to the anti-inflammatory, antioxidant, and anti-apoptotic properties associated with HMOX1. In another study, CBD was shown to be capable of penetrating cells and balancing oxidative stress induced by ultraviolet B-induced and hydrogen peroxide.

In addition, topical application of CBD in preclinical and clinical studies may target peripheral inflammation and help reduce pain associated with certain conditions. Topical application circumvents the central nervous system, which may reduce the risk for CBD-related side effects, the investigators related. These research findings have not been validated in larger clinical trials.

Wound healing may also be a potential target for topical CBD use, as it may be influenced by ECS signaling. Some small research models suggest cannabinoid analogs can generate a wound healing response via activation of CB1 and/or CB2 receptors, anti-inflammatory upregulation, and activation of epidermal growth factor receptors. Similar to other studies looking at topical CBD for skin conditions, the research on wound healing with topical CBD is scarce, it was noted.

Other research has looked into topical CBD for the modulation of hair growth due to major cannabinoid compounds found in hair fibers. Expression of CB1 and CB2 receptors vary within the hair follicle. Models of obese mice show oral ingestion of synthetic antagonist of CB1 promoted hair growth, but there was no similar effect when the antagonist was applied topically. Additional small studies have looked into the potential of topical CBD for hair pigmentation, but the involvement of the ECS in melanogenesis is not yet clearly understood.

The researchers of this study concluded that while the therapeutic potential of CBD for acne, seborrhea, eczema/dermatitis, and skin barrier function is promising, more robust studies are needed to fully validate its efficacy.

Reference

Baswan SM, Klosner AE, Glynn K, et al. Therapeutic potential of cannabidiol (CBD) for skin health and disorders. Clin Cosmet Investig Dermatol. Published online December 8, 2020. doi:10.2147/CCID.S286411

See original here:
The Role of Topical CBD in Skin Disorders: Current Knowledge and Future Directions - Dermatology Advisor

Overview for Psoriasis Market Helps in providing scope and definitions, Key Findings, Growth Drivers, and Various Dynamics.

Psoriasis Market Data and Acquisition Research Study with Trends and Opportunities 2019-2024The study of Psoriasis market is a compilation of the market of Psoriasis broken down into its entirety on the basis of types, application, trends and opportunities, mergers and acquisitions, drivers and restraints, and a global outreach. The detailed study also offers a board interpretation of the Psoriasis industry from a variety of data points that are collected through reputable and verified sources. Furthermore, the study sheds a lights on a market interpretations on a global scale which is further distributed through distribution channels, generated incomes sources and a marginalized market space where most trade occurs.

Along with a generalized market study, the report also consists of the risks that are often neglected when it comes to the Psoriasis industry in a comprehensive manner. The study is also divided in an analytical space where the forecast is predicted through a primary and secondary research methodologies along with an in-house model.

Download PDF Sample of Psoriasis Market report @ https://hongchunresearch.com/request-a-sample/121215

Key players in the global Psoriasis market covered in Chapter 12:Amgen Inc.Biogen IdecStiefel Laboratories Inc.Celgene CorporationJohnson and Johnson (Janssen Biotech Inc.)Eli Lilly and CompanyPfizer Inc.Novartis AGTakeda Pharmaceutical Company LimitedAbbVie Inc.

In Chapter 4 and 14.1, on the basis of types, the Psoriasis market from 2015 to 2025 is primarily split into:SystemicPhototherapyTopical TreatmentOthers

In Chapter 5 and 14.2, on the basis of applications, the Psoriasis market from 2015 to 2025 covers:InjectableTropicalOral

Geographically, the detailed analysis of consumption, revenue, market share and growth rate, historic and forecast (2015-2025) of the following regions are covered in Chapter 6, 7, 8, 9, 10, 11, 14:North America (Covered in Chapter 7 and 14)United StatesCanadaMexicoEurope (Covered in Chapter 8 and 14)GermanyUKFranceItalySpainRussiaOthersAsia-Pacific (Covered in Chapter 9 and 14)ChinaJapanSouth KoreaAustraliaIndiaSoutheast AsiaOthersMiddle East and Africa (Covered in Chapter 10 and 14)Saudi ArabiaUAEEgyptNigeriaSouth AfricaOthersSouth America (Covered in Chapter 11 and 14)BrazilArgentinaColumbiaChileOthersRegional scope can be customized

For a global outreach, the Psoriasis study also classifies the market into a global distribution where key market demographics are established based on the majority of the market share. The following markets that are often considered for establishing a global outreach are North America, Europe, Asia, and the Rest of the World. Depending on the study, the following markets are often interchanged, added, or excluded as certain markets only adhere to certain products and needs.

Here is a short glance at what the study actually encompasses:Study includes strategic developments, latest product launches, regional growth markers and mergers & acquisitionsRevenue, cost price, capacity & utilizations, import/export rates and market shareForecast predictions are generated from analytical data sources and calculated through a series of in-house processes.

However, based on requirements, this report could be customized for specific regions and countries.

Brief about Psoriasis Market Report with [emailprotected]https://hongchunresearch.com/report/psoriasis-market-size-2020-121215

Some Point of Table of Content:

Chapter One: Psoriasis Introduction and Market Overview

Chapter Two: Executive Summary

Chapter Three: Industry Chain Analysis

Chapter Four: Global Psoriasis Market, by Type

Chapter Five: Psoriasis Market, by Application

Chapter Six: Global Psoriasis Market Analysis by Regions

Chapter Seven: North America Psoriasis Market Analysis by Countries

Chapter Eight: Europe Psoriasis Market Analysis by Countries

Chapter Nine: Asia Pacific Psoriasis Market Analysis by Countries

Chapter Ten: Middle East and Africa Psoriasis Market Analysis by Countries

Chapter Eleven: South America Psoriasis Market Analysis by Countries

Chapter Twelve: Competitive Landscape 12.1 Amgen Inc. 12.1.1 Amgen Inc. Basic Information 12.1.2 Psoriasis Product Introduction 12.1.3 Amgen Inc. Production, Value, Price, Gross Margin 2015-2020 12.2 Biogen Idec 12.2.1 Biogen Idec Basic Information 12.2.2 Psoriasis Product Introduction 12.2.3 Biogen Idec Production, Value, Price, Gross Margin 2015-2020 12.3 Stiefel Laboratories Inc. 12.3.1 Stiefel Laboratories Inc. Basic Information 12.3.2 Psoriasis Product Introduction 12.3.3 Stiefel Laboratories Inc. Production, Value, Price, Gross Margin 2015-2020 12.4 Celgene Corporation 12.4.1 Celgene Corporation Basic Information 12.4.2 Psoriasis Product Introduction 12.4.3 Celgene Corporation Production, Value, Price, Gross Margin 2015-2020 12.5 Johnson and Johnson (Janssen Biotech Inc.) 12.5.1 Johnson and Johnson (Janssen Biotech Inc.) Basic Information 12.5.2 Psoriasis Product Introduction 12.5.3 Johnson and Johnson (Janssen Biotech Inc.) Production, Value, Price, Gross Margin 2015-2020 12.6 Eli Lilly and Company 12.6.1 Eli Lilly and Company Basic Information 12.6.2 Psoriasis Product Introduction 12.6.3 Eli Lilly and Company Production, Value, Price, Gross Margin 2015-2020 12.7 Pfizer Inc. 12.7.1 Pfizer Inc. Basic Information 12.7.2 Psoriasis Product Introduction 12.7.3 Pfizer Inc. Production, Value, Price, Gross Margin 2015-2020 12.8 Novartis AG 12.8.1 Novartis AG Basic Information 12.8.2 Psoriasis Product Introduction 12.8.3 Novartis AG Production, Value, Price, Gross Margin 2015-2020 12.9 Takeda Pharmaceutical Company Limited 12.9.1 Takeda Pharmaceutical Company Limited Basic Information 12.9.2 Psoriasis Product Introduction 12.9.3 Takeda Pharmaceutical Company Limited Production, Value, Price, Gross Margin 2015-2020 12.10 AbbVie Inc. 12.10.1 AbbVie Inc. Basic Information 12.10.2 Psoriasis Product Introduction 12.10.3 AbbVie Inc. Production, Value, Price, Gross Margin 2015-2020

Chapter Thirteen: Industry Outlook continued

Check [emailprotected] https://hongchunresearch.com/check-discount/121215

List of tablesList of Tables and Figures Figure Product Picture of Psoriasis Table Product Specification of Psoriasis Table Psoriasis Key Market Segments Table Key Players Psoriasis Covered Figure Global Psoriasis Market Size, 2015 2025 Table Different Types of Psoriasis Figure Global Psoriasis Value ($) Segment by Type from 2015-2020 Figure Global Psoriasis Market Share by Types in 2019 Table Different Applications of Psoriasis Figure Global Psoriasis Value ($) Segment by Applications from 2015-2020 Figure Global Psoriasis Market Share by Applications in 2019 Figure Global Psoriasis Market Share by Regions in 2019 Figure North America Psoriasis Production Value ($) and Growth Rate (2015-2020) Figure Europe Psoriasis Production Value ($) and Growth Rate (2015-2020) Figure Asia Pacific Psoriasis Production Value ($) and Growth Rate (2015-2020) Figure Middle East and Africa Psoriasis Production Value ($) and Growth Rate (2015-2020) Figure South America Psoriasis Production Value ($) and Growth Rate (2015-2020) Table Global COVID-19 Status and Economic Overview Figure Global COVID-19 Status Figure COVID-19 Comparison of Major Countries Figure Industry Chain Analysis of Psoriasis Table Upstream Raw Material Suppliers of Psoriasis with Contact Information Table Major Players Headquarters, and Service Area of Psoriasis Figure Major Players Production Value Market Share of Psoriasis in 2019 Table Major Players Psoriasis Product Types in 2019 Figure Production Process of Psoriasis Figure Manufacturing Cost Structure of Psoriasis Figure Channel Status of Psoriasis Table Major Distributors of Psoriasis with Contact Information Table Major Downstream Buyers of Psoriasis with Contact Information Table Global Psoriasis Value ($) by Type (2015-2020) Table Global Psoriasis Value Share by Type (2015-2020) Figure Global Psoriasis Value Share by Type (2015-2020) Table Global Psoriasis Production by Type (2015-2020) Table Global Psoriasis Production Share by Type (2015-2020) Figure Global Psoriasis Production Share by Type (2015-2020) Figure Global Psoriasis Value ($) and Growth Rate of Systemic (2015-2020) Figure Global Psoriasis Value ($) and Growth Rate of Phototherapy (2015-2020) Figure Global Psoriasis Value ($) and Growth Rate of Topical Treatment (2015-2020) Figure Global Psoriasis Value ($) and Growth Rate of Others (2015-2020) Figure Global Psoriasis Price by Type (2015-2020) Figure Downstream Market Overview Table Global Psoriasis Consumption by Application (2015-2020) Table Global Psoriasis Consumption Market Share by Application (2015-2020) Figure Global Psoriasis Consumption Market Share by Application (2015-2020) Figure Global Psoriasis Consumption and Growth Rate of Injectable (2015-2020) Figure Global Psoriasis Consumption and Growth Rate of Tropical (2015-2020) Figure Global Psoriasis Consumption and Growth Rate of Oral (2015-2020) Figure Global Psoriasis Sales and Growth Rate (2015-2020) Figure Global Psoriasis Revenue (M USD) and Growth (2015-2020) Table Global Psoriasis Sales by Regions (2015-2020) Table Global Psoriasis Sales Market Share by Regions (2015-2020) Table Global Psoriasis Revenue (M USD) by Regions (2015-2020) Table Global Psoriasis Revenue Market Share by Regions (2015-2020) Table Global Psoriasis Revenue Market Share by Regions in 2015 Table Global Psoriasis Revenue Market Share by Regions in 2019 Figure North America Psoriasis Sales and Growth Rate (2015-2020) Figure Europe Psoriasis Sales and Growth Rate (2015-2020) Figure Asia-Pacific Psoriasis Sales and Growth Rate (2015-2020) Figure Middle East and Africa Psoriasis Sales and Growth Rate (2015-2020) Figure South America Psoriasis Sales and Growth Rate (2015-2020) Figure North America COVID-19 Status Figure North America COVID-19 Confirmed Cases Major Distribution Figure North America Psoriasis Revenue (M USD) and Growth (2015-2020) Table North America Psoriasis Sales by Countries (2015-2020) Table North America Psoriasis Sales Market Share by Countries (2015-2020) Table North America Psoriasis Revenue (M USD) by Countries (2015-2020) Table North America Psoriasis Revenue Market Share by Countries (2015-2020) Figure United States Psoriasis Sales and Growth Rate (2015-2020) Figure Canada Psoriasis Sales and Growth Rate (2015-2020) Figure Mexico Psoriasis Sales and Growth (2015-2020) Figure Europe COVID-19 Status Figure Europe COVID-19 Confirmed Cases Major Distribution Figure Europe Psoriasis Revenue (M USD) and Growth (2015-2020) Table Europe Psoriasis Sales by Countries (2015-2020) Table Europe Psoriasis Sales Market Share by Countries (2015-2020) Table Europe Psoriasis Revenue (M USD) by Countries (2015-2020) Table Europe Psoriasis Revenue Market Share by Countries (2015-2020) Figure Germany Psoriasis Sales and Growth Rate (2015-2020) Figure UK Psoriasis Sales and Growth Rate (2015-2020) Figure France Psoriasis Sales and Growth (2015-2020) Figure Italy Psoriasis Sales and Growth (2015-2020) Figure Spain Psoriasis Sales and Growth (2015-2020) Figure Russia Psoriasis Sales and Growth (2015-2020) Figure Asia Pacific COVID-19 Status Figure Asia Pacific Psoriasis Revenue (M USD) and Growth (2015-2020) Table Asia Pacific Psoriasis Sales by Countries (2015-2020) Table Asia Pacific Psoriasis Sales Market Share by Countries (2015-2020) Table Asia Pacific Psoriasis Revenue (M USD) by Countries (2015-2020) Table Asia Pacific Psoriasis Revenue Market Share by Countries (2015-2020) Figure China Psoriasis Sales and Growth Rate (2015-2020) Figure Japan Psoriasis Sales and Growth Rate (2015-2020) Figure South Korea Psoriasis Sales and Growth (2015-2020) Figure India Psoriasis Sales and Growth (2015-2020) Figure Southeast Asia Psoriasis Sales and Growth (2015-2020) Figure Australia Psoriasis Sales and Growth (2015-2020) Figure Middle East Psoriasis Revenue (M USD) and Growth (2015-2020) continued

About HongChun Research: HongChun Research main aim is to assist our clients in order to give a detailed perspective on the current market trends and build long-lasting connections with our clientele. Our studies are designed to provide solid quantitative facts combined with strategic industrial insights that are acquired from proprietary sources and an in-house model.

Contact Details: Jennifer GrayManager Global Sales+ 852 8170 0792[emailprotected]

NOTE: Our report does take into account the impact of coronavirus pandemic and dedicates qualitative as well as quantitative sections of information within the report that emphasizes the impact of COVID-19.

As this pandemic is ongoing and leading to dynamic shifts in stocks and businesses worldwide, we take into account the current condition and forecast the market data taking into consideration the micro and macroeconomic factors that will be affected by the pandemic.

https://neighborwebsj.com/

See the article here:
Impact Of Covid-19 on Psoriasis Market 2021 Industry Challenges, Business Overview and Forecast Research Study 2026 NeighborWebSJ - NeighborWebSJ